Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xin Fu

Showing results (911-920 of 1,641) with videos related to

Pageof 165
Sort By:
Molecules (Basel, Switzerland)|October 3, 2012
A new saponin from tea seed pomace (Camellia oleifera Abel) and its protective effect on PC12 cellsXin-Fu Zhang, Ying-Ying Han, Guan-Hu Bao, et al.
Neurotoxicity Research|May 31, 2022
Neuroprotection of Oral Edaravone on Middle Cerebral Artery Occlusion in RatsLi-Qin Zhao, Ankit Parikh, Yun-Xia Xiong, et al.
Scientific Reports|December 12, 2018
T cell-derived lymphotoxin limits Th1 response during HSV-1 infectionKaiting Yang, Yong Liang, Zhichen Sun, et al.
Zhongguo Gu Shang = China Journal of Orthopaedics and Traumatology|December 25, 2008
[Treatment of fracture of tibia and fibula with three dimensional diaplasis fixation]Zhao-Dong Yan, Yong Zhao, Tai-Biao Zhang, et al.
The Journal of Experimental Medicine|September 27, 2022
An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis deliveryJiao Shen, Zhuangzhi Zou, Jingya Guo, et al.
World Neurosurgery|February 28, 2016
Minimally Invasive Transforaminal Lumbar Interbody Fusion Using Expandable Technology: A Clinical and Radiographic Analysis of 50 PatientsCholl W Kim, Todd M Doerr, Ingrid Y Luna, et al.
BMC Genomics|April 29, 2018
Ginkgo biloba's footprint of dynamic Pleistocene history dates back only 390,000 years agoNora Hohmann, Eva M Wolf, Philippe Rigault, et al.
Plos One|December 3, 2014
BMP4 increases the expression of TRPC and basal [Ca2+]i via the p38MAPK and ERK1/2 pathways independent of BMPRII in PASMCsYi Zhang, Yingfeng Wang, Kai Yang, et al.
Nature Communications|October 8, 2021
Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistanceXuezhi Cao, Yong Liang, Zhenxiang Hu, et al.
Journal of Biomedical Nanotechnology|October 28, 2021
Sensitive Tumor Cell Line for Annonaceous Acetogenins and High Therapeutic Efficacy at a Low Dose for Choriocarcinoma TherapyHui Ao, Hao-Wen Li, Li-Kang Lu, et al.
Pageof 165

Showing results (911-920 of 1,641) with videos related to

Sort By:
Pageof 165
Molecules (Basel, Switzerland)|October 3, 2012
A new saponin from tea seed pomace (Camellia oleifera Abel) and its protective effect on PC12 cellsXin-Fu Zhang, Ying-Ying Han, Guan-Hu Bao, et al.
Neurotoxicity Research|May 31, 2022
Neuroprotection of Oral Edaravone on Middle Cerebral Artery Occlusion in RatsLi-Qin Zhao, Ankit Parikh, Yun-Xia Xiong, et al.
Scientific Reports|December 12, 2018
T cell-derived lymphotoxin limits Th1 response during HSV-1 infectionKaiting Yang, Yong Liang, Zhichen Sun, et al.
Zhongguo Gu Shang = China Journal of Orthopaedics and Traumatology|December 25, 2008
[Treatment of fracture of tibia and fibula with three dimensional diaplasis fixation]Zhao-Dong Yan, Yong Zhao, Tai-Biao Zhang, et al.
The Journal of Experimental Medicine|September 27, 2022
An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis deliveryJiao Shen, Zhuangzhi Zou, Jingya Guo, et al.
World Neurosurgery|February 28, 2016
Minimally Invasive Transforaminal Lumbar Interbody Fusion Using Expandable Technology: A Clinical and Radiographic Analysis of 50 PatientsCholl W Kim, Todd M Doerr, Ingrid Y Luna, et al.
BMC Genomics|April 29, 2018
Ginkgo biloba's footprint of dynamic Pleistocene history dates back only 390,000 years agoNora Hohmann, Eva M Wolf, Philippe Rigault, et al.
Plos One|December 3, 2014
BMP4 increases the expression of TRPC and basal [Ca2+]i via the p38MAPK and ERK1/2 pathways independent of BMPRII in PASMCsYi Zhang, Yingfeng Wang, Kai Yang, et al.
Nature Communications|October 8, 2021
Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistanceXuezhi Cao, Yong Liang, Zhenxiang Hu, et al.
Journal of Biomedical Nanotechnology|October 28, 2021
Sensitive Tumor Cell Line for Annonaceous Acetogenins and High Therapeutic Efficacy at a Low Dose for Choriocarcinoma TherapyHui Ao, Hao-Wen Li, Li-Kang Lu, et al.
Pageof 165